News List

Novartis' asciminib bests Pfizer's Bosulif in phase 3 leukemia trial

Novartis’ asciminib hasoutperformedPfizer’s Bosulif in a phase 3 chronic myeloid leukemia (CML) stud

Hengrui announces new drug SHR7280

On October 11, 2021, Jiangsu Hengrui Pharmaceuticals Co., Ltd. announced that SHR0302, for the treat

Novartis secures new approval in China for Cosentyx® (secukinumab) in pediatric psoriasis

August 17, 2021 – Novartis today announced that the China National Medical Products Administration (

Bayer’s new symptomatic chronic heart failure treatment Verquvo™ (vericiguat) approved in EU

Berlin, Germany, July 21, 2021– The European Commission has granted marketing authorization in the E

USFDA approves KIT inhibitor Ayvakit (Avatinib)

CStone's partner Blueprint Medicines recently announced that the U.S. Food and Drug Administrati

Xofluza was approved in China

On April 29, 2021, Roche China announced that its innovative influenza drug Xofluza® (Mabaloxavir) h

Tagrisso approved in China in early lung cancer

AstraZeneca'sTagrisso(osimertinib) has been approved in China for the adjuvant treatment of pati